IGBP1P3

Across TCGA pan-cancer cohorts, IGBP1P3 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated IGBP1P3 data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher IGBP1P3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated IGBP1P3 expression acts as an unfavorable survival marker, although some lineages such as UVM and LIHC show a favorable association.

ESCA, UVM, and LUSC are the cancer types where IGBP1P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Median	All	0.426	0.665	<.001	29	view →
UVM	OS	Tertile	II,III,IV	0.968	0.797	.022	26	view →
LUSC	DFS	Tertile	III,IV	0.032	0.791	<.001	18	view →
COAD	OS	Tertile	All	0.521	0.701	.028	18	view →
OV	OS	Median	All	0.651	0.716	.034	16	view →
SKCM	OS	Tertile	II,III,IV	0.726	0.870	.010	12	view →
LIHC	OS	Tertile	All	0.897	0.440	.021	3	view →
THCA	DFS	Quartile	IV	0.922	0.500	.047	2	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

IGBP1P3–ESCA (OS)

Open the ESCA breakdown →